Internal Medicine · Albertville, AL
NPI
1932190188
Since 2005
Specialty
Internal Medicine
Code 173000000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9511 US Highway 431
Albertville, AL, 35950
Phone (256) 891-7001
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
1,173 services
Medicare patients, 2024
109
Average age 63
Drug cost, 2024
$584K
4,862 prescriptions
Company payments, 2025
$513
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James R Austin was code 80305 (drug tests), 261 times for 63 patients. In total James R Austin billed 1,173 services in 41 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80305 Drug Tests | Office | 261 | 63 | $12.34 | $3,220 |
| 99213 Office E&M - Established | Office | 196 | 65 | $50.32 | $9,862 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 104 | 24 | $0.30 | $31.64 |
| 99214 Office E&M - Established | Office | 98 | 51 | $74.80 | $7,330 |
| 82947 Clinical Chemistry | Office | 80 | 28 | $3.85 | $308 |
| 85025 Blood Count | Office | 73 | 59 | $7.24 | $528 |
| 96372 Injection Administration | Office | 63 | 37 | $8.66 | $545 |
| 87804 Immunoassay | Office | 58 | 25 | $14.62 | $848 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 30 | 30 | $16.81 | $504 |
| 87426 Immunoassay | Office | 29 | 25 | $31.22 | $905 |
| 93000 Electrocardiogram | Office | 27 | 26 | $8.39 | $227 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 24 | 24 | $117.48 | $2,820 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 23 | 21 | $4.02 | $92.49 |
| 71046 X-ray - Chest | Office | 21 | 19 | $17.12 | $359 |
By year: 2022 $102K for 3,365 services; 2023 $69K for 2,631 services; 2024 $30K for 1,173 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 261 | 63 | $12.34 | $3,220 |
| 82947 Clinical Chemistry | 80 | 28 | $3.85 | $308 |
| 85025 Blood Count | 73 | 59 | $7.24 | $528 |
| 87804 Immunoassay | 58 | 25 | $14.62 | $848 |
| 87426 Immunoassay | 29 | 25 | $31.22 | $905 |
Medicare prescription drug claims, 2024
In 2024, the drug James R Austin prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 838 prescriptions and refills. In total James R Austin wrote 4,862 Medicare prescriptions that cost $584K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 838 | 838 | 96 | $127K |
| Gabapentin Generic | 311 | 317 | 56 | $2,800 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 253 | 253 | 51 | $3,544 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 142 | 142 | 53 | $3,078 |
| Lisinopril Generic | 134 | 210 | 46 | $481 |
| Atorvastatin Calcium Generic | 132 | 231 | 39 | $862 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 119 | 119 | 17 | $52K |
| Azithromycin Generic | 100 | 100 | 79 | $432 |
| Omeprazole Generic | 95 | 158 | 40 | $836 |
| Metformin Hcl Generic | 91 | 153 | 29 | $438 |
| Pregabalin Generic | 88 | 88 | 19 | $1,188 |
| Mounjaro Tirzepatide | 84 | 84 | 29 | $87K |
| Trazodone Hcl Generic | 81 | 134 | 32 | $375 |
| Amlodipine Besylate Generic | 77 | 151 | 27 | $278 |
| Pantoprazole Sodium Generic | 75 | 133 | 25 | $433 |
Brand drugs: 656 claims; generic drugs: 4,183 claims; opioid claims: 270.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James R Austin $513 ($513 in general payments such as food, travel and fees) from 8 companies. The largest payer was Indivior Inc. with $134.
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. INDV | 4 | $134 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $98.11 |
| Novo Nordisk Inc NVO | 4 | $69.48 |
| Abbvie Inc. ABBV | 4 | $62.68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $49.82 |
| Braeburn Inc. | 2 | $44.33 |
| Exact Sciences Corporation EXAS | 2 | $35.29 |
| Gilead Sciences, Inc. GILD | 1 | $19.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.